Liu TC - Search Results

1

Development of targeted oncolytic virotherapeutics through translational research.

Liu TC, Hwang TH, Bell JC, Kirn DH. Liu TC, et al. Expert Opin Biol Ther. 2008 Sep;8(9):1381-91. doi: 10.1517/14712598.8.9.1381. Expert Opin Biol Ther. 2008. PMID: 18694356 Review.

2

Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress.

Liu TC, Galanis E, Kirn D. Liu TC, et al. Nat Clin Pract Oncol. 2007 Feb;4(2):101-17. doi: 10.1038/ncponc0736. Nat Clin Pract Oncol. 2007. PMID: 17259931 Review.

3

Translation of targeted oncolytic virotherapeutics from the lab into the clinic, and back again: a high-value iterative loop.

Liu TC, Hwang TH, Bell JC, Kirn DH. Liu TC, et al. Mol Ther. 2008 Jun;16(6):1006-8. doi: 10.1038/mt.2008.70. Mol Ther. 2008. PMID: 18500240 Free article. No abstract available.

4

The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma.

Liu TC, Hwang T, Park BH, Bell J, Kirn DH. Liu TC, et al. Mol Ther. 2008 Sep;16(9):1637-42. doi: 10.1038/mt.2008.143. Epub 2008 Jul 15. Mol Ther. 2008. PMID: 18628758 Free article.

5

Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions.

Liu TC, Kirn D. Liu TC, et al. Cancer Res. 2007 Jan 15;67(2):429-32. doi: 10.1158/0008-5472.CAN-06-2871. Cancer Res. 2007. PMID: 17234747 Review.

6

Targeting the untargetable: oncolytic virotherapy for the cancer stem cell.

Liu TC, Kirn D. Liu TC, et al. Mol Ther. 2007 Dec;15(12):2060-1. doi: 10.1038/sj.mt.6300337. Mol Ther. 2007. PMID: 18026182 Free article. No abstract available.

7

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial.

Park BH, Hwang T, Liu TC, Sze DY, Kim JS, Kwon HC, Oh SY, Han SY, Yoon JH, Hong SH, Moon A, Speth K, Park C, Ahn YJ, Daneshmand M, Rhee BG, Pinedo HM, Bell JC, Kirn DH. Park BH, et al. Among authors: liu tc. Lancet Oncol. 2008 Jun;9(6):533-42. doi: 10.1016/S1470-2045(08)70107-4. Epub 2008 May 19. Lancet Oncol. 2008. PMID: 18495536 Clinical Trial.

8

Oncolytic adenoviruses for cancer gene therapy.

Liu TC, Thorne SH, Kirn DH. Liu TC, et al. Methods Mol Biol. 2008;433:243-58. doi: 10.1007/978-1-59745-237-3_15. Methods Mol Biol. 2008. PMID: 18679628

9

Oncolytic virotherapy for advanced liver tumours.

Chang JF, Chen PJ, Sze DY, Reid T, Bartlett D, Kirn DH, Liu TC. Chang JF, et al. Among authors: liu tc. J Cell Mol Med. 2009 Jul;13(7):1238-47. doi: 10.1111/j.1582-4934.2008.00563.x. Epub 2008 Oct 23. J Cell Mol Med. 2009. PMID: 19175689 Free PMC article. Review.

10

Targeted genetic and viral therapy for advanced head and neck cancers.

Huang PI, Chang JF, Kirn DH, Liu TC. Huang PI, et al. Among authors: liu tc. Drug Discov Today. 2009 Jun;14(11-12):570-8. doi: 10.1016/j.drudis.2009.03.008. Epub 2009 Mar 17. Drug Discov Today. 2009. PMID: 19508919 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

862 results

Search Page